A comprehensive evaluation of a novel targeted-sequencing workflow for Mycobacterium species identification and anti-tuberculosis drug-resistance detection
The TB Pro assay represents a sensitive and specific solution for simultaneous mycobacterial identification and comprehensive drug-resistance profiling, performing robustly on both cultured isolates and direct clinical specimens.
Authors
- Yang Zhou (ORCID: https://orcid.org/0000-0003-4167-6413)
- Hui Xia (ORCID: https://orcid.org/0000-0002-2517-2410)
- Shaojun Pei
- Bing Tian Zhao (ORCID: https://orcid.org/0000-0001-9891-3569)
- 崇匡 佐藤
- Richard Anthony (ORCID: https://orcid.org/0000-0002-0550-5273)
- Xichao Ou (ORCID: https://orcid.org/0000-0002-3126-4450)
- Yuanyuan Song (ORCID: https://orcid.org/0000-0003-1354-8510)
- Zhonghua Qin (ORCID: https://orcid.org/0000-0003-3263-625X)
- Yanlin Zhao
- Ruida Xing (ORCID: https://orcid.org/0000-0001-9696-0214)
- Shengfen Wang
- Lixia Zhang (ORCID: https://orcid.org/0000-0002-5900-5354)
- Hongru Li (ORCID: https://orcid.org/0000-0003-4700-962X)
- Jichun Wang (ORCID: https://orcid.org/0000-0003-0571-2771)
- Yang Zheng (ORCID: https://orcid.org/0000-0003-4259-1542)
- Zexuan Song
Institutions
- Chinese Center For Disease Control and Prevention (CN)
- Anhui Medical University (CN)
- Peking University (CN)
- National Institute for Public Health and the Environment (NL)
- First Affiliated Hospital of Anhui Medical University (CN)
- Beijing Center for Disease Prevention and Control (CN)
- Tianjin haihe hospital (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-06-09
- DOI
- https://doi.org/10.3389/fcimb.2025.1584237
- Citations
- 2
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Chinese Center for Disease Control and Prevention
- Centers for Disease Control and Prevention